Bridget E. Bunner

Array ( [id] => 6401029 [patent_doc_number] => 20100179094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'BISPECIFIC EGFR/IGFIR BINDING MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/625217 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 62313 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20100179094.pdf [firstpage_image] =>[orig_patent_app_number] => 12625217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7566853 [patent_doc_number] => 20110286916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'GENERATION AND CHARACTERIZATION OF ANTI-NOTCH ANTIBODIES FOR THERAPEUTIC AND DIAGNOSTIC USE' [patent_app_type] => utility [patent_app_number] => 13/130441 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 106122 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20110286916.pdf [firstpage_image] =>[orig_patent_app_number] => 13130441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555334 [patent_doc_number] => 08067235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Optimized human T1R2 nucleic acid molecule' [patent_app_type] => utility [patent_app_number] => 12/616340 [patent_app_country] => US [patent_app_date] => 2009-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12209 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067235.pdf [firstpage_image] =>[orig_patent_app_number] => 12616340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7686000 [patent_doc_number] => 20100120141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Screening methods for compounds that modulate the activity of G-protein coupled receptors' [patent_app_type] => utility [patent_app_number] => 12/616361 [patent_app_country] => US [patent_app_date] => 2009-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12212 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120141.pdf [firstpage_image] =>[orig_patent_app_number] => 12616361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697146 [patent_doc_number] => 20110229444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'Neuregulin And Cardiac Stem Cells' [patent_app_type] => utility [patent_app_number] => 13/131668 [patent_app_country] => US [patent_app_date] => 2009-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9426 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229444.pdf [firstpage_image] =>[orig_patent_app_number] => 13131668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6400790 [patent_doc_number] => 20100305003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides' [patent_app_type] => utility [patent_app_number] => 12/590442 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 47743 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305003.pdf [firstpage_image] =>[orig_patent_app_number] => 12590442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6596955 [patent_doc_number] => 20100292155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides' [patent_app_type] => utility [patent_app_number] => 12/590409 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 47739 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292155.pdf [firstpage_image] =>[orig_patent_app_number] => 12590409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236336 [patent_doc_number] => 20100267648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides' [patent_app_type] => utility [patent_app_number] => 12/590236 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 47743 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267648.pdf [firstpage_image] =>[orig_patent_app_number] => 12590236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8737800 [patent_doc_number] => 08409567 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-02 [patent_title] => 'Toll-like receptor 3 antagonists' [patent_app_type] => utility [patent_app_number] => 12/609675 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 34 [patent_no_of_words] => 28940 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12609675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6510287 [patent_doc_number] => 20100261194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'NEUTROKINE-ALPHA ANTIBODIES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/610128 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 162804 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261194.pdf [firstpage_image] =>[orig_patent_app_number] => 12610128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4521121 [patent_doc_number] => 07951381 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Method of stimulating epithelial cell proliferation by administration of gastrointestinal proliferative factor' [patent_app_type] => utility [patent_app_number] => 12/589727 [patent_app_country] => US [patent_app_date] => 2009-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 107 [patent_figures_cnt] => 141 [patent_no_of_words] => 69602 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951381.pdf [firstpage_image] =>[orig_patent_app_number] => 12589727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669078 [patent_doc_number] => 20110318347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'AMINO ACID SEQUENCES TARGETING HUMAN CD4, CXCR4, CCR5, TLR4, ALPHAV INTEGRIN, BETA3-INTEGRIN, BETA1-INTEGRIN, HUMAN ALPHA2-INTEGRIN, CD81, SR-BI, CLAUDIN-1, CLAUDIN-6 AND CLAUDIN-9, RESPECTIVELY, AND NEUTRALIZING VIRAL ENTRY' [patent_app_type] => utility [patent_app_number] => 13/124001 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 131477 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13124001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479101 [patent_doc_number] => 20100092462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Methods for Suppressing Toll-Like Receptor Activity' [patent_app_type] => utility [patent_app_number] => 12/572338 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9264 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092462.pdf [firstpage_image] =>[orig_patent_app_number] => 12572338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6372767 [patent_doc_number] => 20100080808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'ANTI-NOTCH2 ANTIBODIES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/570267 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 51058 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20100080808.pdf [firstpage_image] =>[orig_patent_app_number] => 12570267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427340 [patent_doc_number] => 08703413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Detection of human somatic cell reprogramming' [patent_app_type] => utility [patent_app_number] => 13/120192 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 12852 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13120192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8213472 [patent_doc_number] => 08192738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Targeted antibodies directed to DLL4' [patent_app_type] => utility [patent_app_number] => 12/562268 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 94131 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/192/08192738.pdf [firstpage_image] =>[orig_patent_app_number] => 12562268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579752 [patent_doc_number] => 20110293635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'COMPOSITION AND METHODS FOR MODULATING TOLL-LIKE RECEPTOR ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/119116 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22379 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293635.pdf [firstpage_image] =>[orig_patent_app_number] => 13119116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4612744 [patent_doc_number] => 07989208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Gamma secretase notch biomarkers' [patent_app_type] => utility [patent_app_number] => 12/552361 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9079 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989208.pdf [firstpage_image] =>[orig_patent_app_number] => 12552361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6090351 [patent_doc_number] => 20110218146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'ADIPONECTIN FOR TREATING PULMONARY DISEASE' [patent_app_type] => utility [patent_app_number] => 13/060422 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9362 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218146.pdf [firstpage_image] =>[orig_patent_app_number] => 13060422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6014900 [patent_doc_number] => 20110223183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'HUMAN NOTCH3 BASED FUSION PROTEINS AS DECOY INHIBITORS OF NOTCH3 SIGNALING' [patent_app_type] => utility [patent_app_number] => 13/060254 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 20088 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13060254 [rel_patent_id] =>[rel_patent_doc_number] =>)